Boehringer Advances Novel Combo Therapy in SCLC Trial
INGELHEIM, Germany, April 9, 2026 Boehringer Ingelheim has announced a strategic clinical trial collaboration with BioNTech to evaluate a...
biologics
Advertisement
C4 and Roche Expand DAC Cancer Drug Collaboration
WATERTOWN, Mass., April 09, 2026 C4 Therapeutics, Inc. has announced a major expansion of its long-term collaboration with Roche,...
Dyno AI Capsid Licensed by Astellas for Gene Therapy
WATERTOWN, Mass., April 8, 2026 Dyno Therapeutics, Inc. has announced that Astellas Pharma has exercised its option to license...
Immutrin Raises $87M to Advance Amyloidosis Antibody Therapy
CAMBRIDGE, UK, April 8, 2026 Immutrin Ltd has successfully raised £65 million ($87 million) in an oversubscribed Series A...
GSK Secures China Approval for Exdensur in Nasal Polyps Treatment
LONDON, UK, April 8, 2026 GSK has announced that China’s National Medical Products Administration (NMPA) has approved Exdensur (depemokimab),...
Advertisements
Biocon Launches Denosumab Biosimilars in U.S.
BENGALURU, India & BRIDGEWATER, New Jersey, United States, April 7, 2026 Biocon Limited announced the U.S. commercial launch of...
Apotex Wins Approval for DENOZA Biosimilar in Canada
TORONTO, Ontario, Canada, April 7, 2026 Apotex Inc., a leading global pharmaceutical company, announced that Health Canada has approved...
Singlomics Doses First Patient in DXP-106 Trial
BEIJING, China, April 7, 2026 Singlomics Biopharmaceuticals, a clinical-stage biotechnology company focused on antibody therapeutics, announced that the first...
Fortitude Advances T-Cell Therapy for Axial Disease
WALTHAM, Massachusetts, United States, April 7, 2026 Fortitude Biomedicines, Inc. announced progress on its lead immunology program, a first-in-class...
NurExone Strengthens GMP Exosome Supply via BioXtek
TORONTO, Canada; HAIFA, Israel; and POMPANO BEACH, Florida, April 7, 2026 NurExone Biologic Inc. announced that its U.S. subsidiary...
Advertisement
